PhaseRx Inc is biopharmaceutical company focused on developing novel approaches to the delivery of siRNA and other macromolecules. The core delivery platform is based on polymer technology developed in the laboratories of Profs. Pat Stayton and Allan Hoffman at the University of Washington.